Back to Agenda
Data Sharing and Secondary Use of Data
Session Chair(s)
Merete Joergensen, MBA, MSC
Clinical Disclosure and Transparency Expert, Merete-J Consulting, Denmark
Transparency of clinical information and sharing of person level data has been increasing over the last couple of years. Views of the challenges as well as the benefits experienced will be shared. The aim of the session is to share views on how to make the best out of the efforts that are put into sharing the wealth of information.
Learning Objective : i. Describe current national and regional clinical trial transparency regulations and requirements ii. Compare models for coordinating and streamlining clinical trial transparency operations across clinical development platforms and functions iii. Apply concepts from best practices for cross-platform/functions collaboration for timely clinical trial transparency compliance.
Speaker(s)
Oladayo Oyelola, PHD
Trial and Disclosure Operations Consultant, Independent Consultant, United States
Aligning Clinical Trial Transparency Operations with Clinical Development Programme
Martin Schumacher
Professor, Institute for Medical Biometry and Statistics, University of Freiburg, Germany
Experience in Sharing Clinical Data for Secondary Use
Ingeborg Cil, MSC
Lead, Clinical Trial Data Anonymization, Xogene Gmbh, Austria
Sharing of Individual Patient Data (IPD) – Data Utility Considerations
Have an account?